West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc - BRDR

BSP:W2ST34 (USA)   BRDR
R$ 57.06 (0%) Apr 29
46.76
P/B:
9.65
Market Cap:
R$ 145.48B ($ 28.45B)
Enterprise V:
R$ 143.97B ($ 28.15B)
Volume:
7.00
Avg Vol (2M):
6.00
Also Trade In:
Volume:
7.00
Avg Vol (2M):
6.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for West Pharmaceutical Services Inc ( BSP:W2ST34 ) from 2021 to Apr 30 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. West Pharmaceutical Services stock (BSP:W2ST34) PE ratio as of Apr 30 2024 is 46.76. More Details

West Pharmaceutical Services Inc (BSP:W2ST34) PE Ratio (TTM) Chart

To

West Pharmaceutical Services Inc (BSP:W2ST34) PE Ratio (TTM) Historical Data

Total 690
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8
West Pharmaceutical Services PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-30 53.6 2024-02-26 44.1
2024-04-29 53.6 2024-02-23 44.1
2024-04-26 53.6 2024-02-22 44.1
2024-04-25 53.6 2024-02-21 44.1
2024-04-24 53.6 2024-02-20 44.1
2024-04-23 54.2 2024-02-19 44.1
2024-04-22 52.8 2024-02-16 44.1
2024-04-19 51.5 2024-02-15 44.1
2024-04-18 51.5 2024-02-14 44.1
2024-04-17 51.5 2024-02-12 44.1
2024-04-16 51.5 2024-02-09 44.1
2024-04-15 51.5 2024-02-08 44.1
2024-04-12 51.5 2024-02-07 44.1
2024-04-11 51.5 2024-02-06 44.1
2024-04-10 51.5 2024-02-05 44.1
2024-04-09 51.5 2024-02-02 44.1
2024-04-08 51.5 2024-02-01 44.1
2024-04-05 51.5 2024-01-31 44.1
2024-04-04 51.5 2024-01-30 44.1
2024-04-03 51.5 2024-01-29 44.1
2024-04-02 51.5 2024-01-26 44.1
2024-04-01 51.5 2024-01-25 44.1
2024-03-28 51.5 2024-01-24 44.1
2024-03-27 49.0 2024-01-23 44.1
2024-03-26 49.0 2024-01-22 44.1
2024-03-25 44.1 2024-01-19 42.9
2024-03-22 44.1 2024-01-18 42.9
2024-03-21 44.1 2024-01-17 43.2
2024-03-20 44.1 2024-01-16 44.0
2024-03-19 44.1 2024-01-15 44.0
2024-03-18 44.1 2024-01-12 44.0
2024-03-15 44.1 2024-01-11 44.0
2024-03-14 44.1 2024-01-10 44.0
2024-03-13 44.1 2024-01-09 44.0
2024-03-12 44.1 2024-01-08 44.0
2024-03-11 44.1 2024-01-05 44.0
2024-03-08 44.1 2024-01-04 44.0
2024-03-07 44.1 2024-01-03 44.0
2024-03-06 44.1 2024-01-02 44.0
2024-03-05 44.1 2024-01-01 43.8
2024-03-04 44.1 2023-12-29 43.8
2024-03-01 44.1 2023-12-28 43.8
2024-02-29 44.1 2023-12-27 46.0
2024-02-28 44.1 2023-12-26 46.0
2024-02-27 44.1 2023-12-25 46.0

West Pharmaceutical Services Inc (BSP:W2ST34) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

West Pharmaceutical Services Inc logo
West Pharmaceutical Services Inc
NAICS : 339112 SIC : 3841
ISIN : BRW2STBDR007

Share Class Description:

BSP:W2ST34: BRDR
Description
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.